FdaApplication
NDA 204223
Identifiers
- fda_app_no: NDA204223
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | NDA |
| approval_date | 2013-10-30 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MORPHINE SULFATE | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
| MORPHINE SULFATE | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
| MORPHINE SULFATE | MORPHINE SULFATE | 1MG/0.5ML (1MG/0.5ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
| MORPHINE SULFATE | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
| MORPHINE SULFATE | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
| MORPHINE SULFATE | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
6 products